Cellectis S.A. (ALCLS)
Euronext
Closed
Oct 7, 2026
Day's Range
1.1852 wk Range
1.09Overview - ALCLS - Cellectis S.A.
Key Statistics
Valuation
Enterprise Value
3.85M
P/E (Trailing)
‪-1.86‬
P/E (Forward)
‪-0.78‬
PEG Ratio
‪-0.78‬
Price / Sales (TTM)
‪1.96‬
Price / Book
‪2.53‬
EV / EBITDA
‪-0.09‬
Profitability
Gross Margin
‪54.96%‬
Profit Margin
‪-102.33%‬
Operating Margin
‪-340.68%‬
Return on Assets
‪-11.66%‬
Return on Equity
‪-94.53%‬
Ownership
Shares Outstanding
100.69M
Float
48.57M
Held by Insiders
‪48.00%‬
Held by Institutions
‪10.66%‬
Price stats
Beta
‪2.76‬
50-Day Avg
‪2.40‬
200-Day Avg
‪3.01‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Market Cap - ALCLS - Cellectis S.A.
Peers - ALCLS - Cellectis S.A.
Peer Comparison
Compared with companies in Biotechnology listed on Euronext.
- ALCLSEuronextCellectis S.A.125.69MMarket Cap-81.49%52-week change-1.86P/E (Trailing)‪-102.33%‬Profit Margin
- ARGXEuronextargenx SE52.87BMarket Cap+27.69%52-week change36.64P/E (Trailing)‪32.26%‬Profit Margin
- AGNEuronextAegon Ltd.11.21BMarket Cap+10.13%52-week change11.66P/E (Trailing)‪8.62%‬Profit Margin
- ABVXEuronextAbivax SA7.14BMarket Cap+13.43%52-week change-16.96P/E (Trailing)‪0.00%‬Profit Margin
- ALVIOEuronextValerio Tx Corp.279.69MMarket Cap+89.64%52-week change—P/E (Trailing)‪-190.36%‬Profit Margin
- AVTXEuronextAvantium N.V.126.03MMarket Cap-46.80%52-week change-2.94P/E (Trailing)‪-154.30%‬Profit Margin
- ALSENEuronextSensorion SA76.24MMarket Cap-119.13%52-week change-73.93P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - ALCLS - Cellectis S.A.
About
Cellectis S.A. is a clinical-stage biotechnology company focused on gene editing and cell therapy. The company develops allogeneic CAR T-cell product candidates designed for immuno-oncology, along with gene-edited therapies for other serious diseases. Its platform centers on proprietary genome-editing technologies,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
